[1] Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications[J]. Curr Opin Anaesthesiol, 2008, 21 (4): 457-461.[2] Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults[J]. Ann Pharmacother, 2009, 43(12): 2064-2074.[3] Gobel FL, Norstrom LA, Nelson RR, et al. The rate-pressure product as index of myocardial oxygen consumption during exercise in patients with angina pectoris[J]. Circulation, 1978, 57(3): 549-556.[4] GUO TZ, Poree L, Golden W, et al. Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha 2 adrenergic receptors in the rat[J]. Anesthesiology, 1996, 85(4): 846-852.[5] Nelson LE, Lu J, Guo T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J]. Anesthesiology, 2003, 98(2): 428-436.[6] Kendig JJ, Savola MK, Woodley SJ, et al. Alpha 2-adrenoceptors inhibit a nociceptive response in neonatal rat spinal cord[J]. Eur J Pharmacol, 1991, 192(2): 293-300.[7] Lakhlani PP, MacMillan LB, Guo TZ, et al. Substitution of a mutant alpha2a-adrenergic receptor via “hit and run” gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo[J]. Proc Nati Acad Sci USA, 1997, 94(18): 9950-9955.[8] Poree LR, Guo TZ, Kingery WS, et al. The analgesic potency of dexmedetomidine is enhanced after nerve injury: a possible role for peripheral alpha2-adrenoceptors[J]. Anesth Analg, 1998, 87(4): 941-948.[9] Menda F, K?ner O, Sayin M, et al. Dexmedetomidine as an adjunct to anesthetic induction to attenuate hemodynamic response to endotracheal intubation in patients undergoing fast-track CABG[J]. Ann Card Anaesth, 2010, 13(1): 16-21.[10] Yildiz M, Tavlan A, Tuncer S, et al. Effect of dexmedetomidine on haemodynamic responses to laryngoscopy and intubation: perioperative haemodynamics and anaesthetic requirements[J]. Drugs R D, 2006, 7(1): 43-52.[11] Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis[J]. Am J Med, 2003, 114(9): 742-752.[12] Scheinin B, Lindqren L, Randell T, et al. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl[J]. Br J Anaesth, 1992, 68(2): 126-131.[13] Talke P, Chen R, Thomas B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery[J]. Anesth Analg, 2000, 90(4): 834-839. |